Search for content, post, videos

“Early profitable companies are in the investor’s appetite”

Nordic Life Science asked Dan Akschuti, Equity Partner/Biotech Analyst, Pareto Securities, about his predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you predict will be the dominant market trend within life sciences this year?
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.